Global Sexually Transmitted Diseases (STD) Testing Market Size, Status and Forecast 2024-2031

Report ID: 918780 | Published Date: Sep 2024 | No. of Page: 106 | Base Year: 2023 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Chlamydia
        1.2.3 Syphilis
        1.2.4 Gonorrhea
        1.2.5 Herpes Simplex Virus
        1.2.6 Human Papilloma Virus
        1.2.7 Human Immunodeficiency Virus
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Sexually Transmitted Diseases (STD) Testing Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Laboratory Testing
        1.3.3 Point of Care (POC) Testing
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Sexually Transmitted Diseases (STD) Testing Market Perspective (2016-2027)
    2.2 Sexually Transmitted Diseases (STD) Testing Growth Trends by Regions
        2.2.1 Sexually Transmitted Diseases (STD) Testing Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Sexually Transmitted Diseases (STD) Testing Historic Market Share by Regions (2016-2021)
        2.2.3 Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Regions (2022-2027)
    2.3 Sexually Transmitted Diseases (STD) Testing Industry Dynamic
        2.3.1 Sexually Transmitted Diseases (STD) Testing Market Trends
        2.3.2 Sexually Transmitted Diseases (STD) Testing Market Drivers
        2.3.3 Sexually Transmitted Diseases (STD) Testing Market Challenges
        2.3.4 Sexually Transmitted Diseases (STD) Testing Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Sexually Transmitted Diseases (STD) Testing Players by Revenue
        3.1.1 Global Top Sexually Transmitted Diseases (STD) Testing Players by Revenue (2016-2021)
        3.1.2 Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Players (2016-2021)
    3.2 Global Sexually Transmitted Diseases (STD) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Sexually Transmitted Diseases (STD) Testing Revenue
    3.4 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio
        3.4.1 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases (STD) Testing Revenue in 2020
    3.5 Sexually Transmitted Diseases (STD) Testing Key Players Head office and Area Served
    3.6 Key Players Sexually Transmitted Diseases (STD) Testing Product Solution and Service
    3.7 Date of Enter into Sexually Transmitted Diseases (STD) Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Sexually Transmitted Diseases (STD) Testing Breakdown Data by Type
    4.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Type (2016-2021)
    4.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Type (2022-2027)

5 Sexually Transmitted Diseases (STD) Testing Breakdown Data by Application
    5.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Application (2016-2021)
    5.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Sexually Transmitted Diseases (STD) Testing Market Size (2016-2027)
    6.2 North America Sexually Transmitted Diseases (STD) Testing Market Size by Type
        6.2.1 North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2016-2021)
        6.2.2 North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2022-2027)
        6.2.3 North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2016-2027)
    6.3 North America Sexually Transmitted Diseases (STD) Testing Market Size by Application
        6.3.1 North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2016-2021)
        6.3.2 North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2022-2027)
        6.3.3 North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2016-2027)
    6.4 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country
        6.4.1 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2016-2021)
        6.4.2 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size (2016-2027)
    7.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type
        7.2.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2016-2021)
        7.2.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2022-2027)
        7.2.3 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2016-2027)
    7.3 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application
        7.3.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2016-2021)
        7.3.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2022-2027)
        7.3.3 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2016-2027)
    7.4 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country
        7.4.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2016-2021)
        7.4.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size (2016-2027)
    8.2 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Type
        8.2.1 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Type (2016-2027)
    8.3 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Application
        8.3.1 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Application (2016-2027)
    8.4 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region
        8.4.1 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Sexually Transmitted Diseases (STD) Testing Market Size (2016-2027)
    9.2 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type
        9.2.1 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2016-2021)
        9.2.2 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2022-2027)
        9.2.3 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2016-2027)
    9.3 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application
        9.3.1 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2016-2021)
        9.3.2 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2022-2027)
        9.3.3 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2016-2027)
    9.4 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country
        9.4.1 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2016-2021)
        9.4.2 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size (2016-2027)
    10.2 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Type
        10.2.1 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Type (2016-2027)
    10.3 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Application
        10.3.1 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Application (2016-2027)
    10.4 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country
        10.4.1 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 ROCHE HOLDINGS
        11.1.1 ROCHE HOLDINGS Company Details
        11.1.2 ROCHE HOLDINGS Business Overview
        11.1.3 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Introduction
        11.1.4 ROCHE HOLDINGS Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
        11.1.5 ROCHE HOLDINGS Recent Development
    11.2 BIOMERIEUX
        11.2.1 BIOMERIEUX Company Details
        11.2.2 BIOMERIEUX Business Overview
        11.2.3 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Introduction
        11.2.4 BIOMERIEUX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
        11.2.5 BIOMERIEUX Recent Development
    11.3 HOLOGIC
        11.3.1 HOLOGIC Company Details
        11.3.2 HOLOGIC Business Overview
        11.3.3 HOLOGIC Sexually Transmitted Diseases (STD) Testing Introduction
        11.3.4 HOLOGIC Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
        11.3.5 HOLOGIC Recent Development
    11.4 BECTON DICKINSON
        11.4.1 BECTON DICKINSON Company Details
        11.4.2 BECTON DICKINSON Business Overview
        11.4.3 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Introduction
        11.4.4 BECTON DICKINSON Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
        11.4.5 BECTON DICKINSON Recent Development
    11.5 ORASURE
        11.5.1 ORASURE Company Details
        11.5.2 ORASURE Business Overview
        11.5.3 ORASURE Sexually Transmitted Diseases (STD) Testing Introduction
        11.5.4 ORASURE Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
        11.5.5 ORASURE Recent Development
    11.6 DANAHER
        11.6.1 DANAHER Company Details
        11.6.2 DANAHER Business Overview
        11.6.3 DANAHER Sexually Transmitted Diseases (STD) Testing Introduction
        11.6.4 DANAHER Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
        11.6.5 DANAHER Recent Development
    11.7 AFFYMETRIX
        11.7.1 AFFYMETRIX Company Details
        11.7.2 AFFYMETRIX Business Overview
        11.7.3 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Introduction
        11.7.4 AFFYMETRIX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
        11.7.5 AFFYMETRIX Recent Development
    11.8 ABBOTT LABORATORIES
        11.8.1 ABBOTT LABORATORIES Company Details
        11.8.2 ABBOTT LABORATORIES Business Overview
        11.8.3 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
        11.8.4 ABBOTT LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
        11.8.5 ABBOTT LABORATORIES Recent Development
    11.9 BIO-RAD LABORATORIES
        11.9.1 BIO-RAD LABORATORIES Company Details
        11.9.2 BIO-RAD LABORATORIES Business Overview
        11.9.3 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
        11.9.4 BIO-RAD LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
        11.9.5 BIO-RAD LABORATORIES Recent Development
    11.10 DIASORIN
        11.10.1 DIASORIN Company Details
        11.10.2 DIASORIN Business Overview
        11.10.3 DIASORIN Sexually Transmitted Diseases (STD) Testing Introduction
        11.10.4 DIASORIN Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
        11.10.5 DIASORIN Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Chlamydia
    Table 3. Key Players of Syphilis
    Table 4. Key Players of Gonorrhea
    Table 5. Key Players of Herpes Simplex Virus
    Table 6. Key Players of Human Papilloma Virus
    Table 7. Key Players of Human Immunodeficiency Virus
    Table 8. Key Players of Others
    Table 9. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Sexually Transmitted Diseases (STD) Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global Sexually Transmitted Diseases (STD) Testing Market Size by Regions (2016-2021) & (US$ Million)
    Table 12. Global Sexually Transmitted Diseases (STD) Testing Market Share by Regions (2016-2021)
    Table 13. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 14. Global Sexually Transmitted Diseases (STD) Testing Market Share by Regions (2022-2027)
    Table 15. Sexually Transmitted Diseases (STD) Testing Market Trends
    Table 16. Sexually Transmitted Diseases (STD) Testing Market Drivers
    Table 17. Sexually Transmitted Diseases (STD) Testing Market Challenges
    Table 18. Sexually Transmitted Diseases (STD) Testing Market Restraints
    Table 19. Global Sexually Transmitted Diseases (STD) Testing Revenue by Players (2016-2021) & (US$ Million)
    Table 20. Global Sexually Transmitted Diseases (STD) Testing Market Share by Players (2016-2021)
    Table 21. Global Top Sexually Transmitted Diseases (STD) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sexually Transmitted Diseases (STD) Testing as of 2020)
    Table 22. Ranking of Global Top Sexually Transmitted Diseases (STD) Testing Companies by Revenue (US$ Million) in 2020
    Table 23. Global 5 Largest Players Market Share by Sexually Transmitted Diseases (STD) Testing Revenue (CR5 and HHI) & (2016-2021)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Sexually Transmitted Diseases (STD) Testing Product Solution and Service
    Table 26. Date of Enter into Sexually Transmitted Diseases (STD) Testing Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Sexually Transmitted Diseases (STD) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 29. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2016-2021)
    Table 30. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 31. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 32. Global Sexually Transmitted Diseases (STD) Testing Market Size Share by Application (2016-2021) & (US$ Million)
    Table 33. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Application (2016-2021)
    Table 34. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 35. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 36. North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 37. North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 38. North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2016-2021) (US$ Million)
    Table 39. North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 40. North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 41. North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 42. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 43. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 44. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2016-2021) (US$ Million)
    Table 45. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 46. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 47. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 48. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Application (2016-2021) (US$ Million)
    Table 51. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 52. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2016-2021) & (US$ Million) 
    Table 53. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2022-2027) & (US$ Million) 
    Table 54. Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 55. Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 56. Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2016-2021) (US$ Million)
    Table 57. Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 58. Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 59. Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 60. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Application (2016-2021) (US$ Million)
    Table 63. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 64. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 65. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 66. ROCHE HOLDINGS Company Details
    Table 67. ROCHE HOLDINGS Business Overview
    Table 68. ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Product
    Table 69. ROCHE HOLDINGS Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021) & (US$ Million)
    Table 70. ROCHE HOLDINGS Recent Development
    Table 71. BIOMERIEUX Company Details
    Table 72. BIOMERIEUX Business Overview
    Table 73. BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Product
    Table 74. BIOMERIEUX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021) & (US$ Million)
    Table 75. BIOMERIEUX Recent Development
    Table 76. HOLOGIC Company Details
    Table 77. HOLOGIC Business Overview
    Table 78. HOLOGIC Sexually Transmitted Diseases (STD) Testing Product
    Table 79. HOLOGIC Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021) & (US$ Million)
    Table 80. HOLOGIC Recent Development
    Table 81. BECTON DICKINSON Company Details
    Table 82. BECTON DICKINSON Business Overview
    Table 83. BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Product
    Table 84. BECTON DICKINSON Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021) & (US$ Million)
    Table 85. BECTON DICKINSON Recent Development
    Table 86. ORASURE Company Details
    Table 87. ORASURE Business Overview
    Table 88. ORASURE Sexually Transmitted Diseases (STD) Testing Product
    Table 89. ORASURE Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021) & (US$ Million)
    Table 90. ORASURE Recent Development
    Table 91. DANAHER Company Details
    Table 92. DANAHER Business Overview
    Table 93. DANAHER Sexually Transmitted Diseases (STD) Testing Product
    Table 94. DANAHER Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021) & (US$ Million)
    Table 95. DANAHER Recent Development
    Table 96. AFFYMETRIX Company Details
    Table 97. AFFYMETRIX Business Overview
    Table 98. AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Product
    Table 99. AFFYMETRIX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021) & (US$ Million)
    Table 100. AFFYMETRIX Recent Development
    Table 101. ABBOTT LABORATORIES Company Details
    Table 102. ABBOTT LABORATORIES Business Overview
    Table 103. ABBOTT LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021) & (US$ Million)
    Table 104. ABBOTT LABORATORIES Recent Development
    Table 105. BIO-RAD LABORATORIES Company Details
    Table 106. BIO-RAD LABORATORIES Business Overview
    Table 107. BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Product
    Table 108. BIO-RAD LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021) & (US$ Million)
    Table 109. BIO-RAD LABORATORIES Recent Development
    Table 110. DIASORIN Company Details
    Table 111. DIASORIN Business Overview
    Table 112. DIASORIN Sexually Transmitted Diseases (STD) Testing Product
    Table 113. DIASORIN Revenue in Sexually Transmitted Diseases (STD) Testing Business (2016-2021) & (US$ Million)
    Table 114. DIASORIN Recent Development
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sexually Transmitted Diseases (STD) Testing Market Share by Type: 2020 VS 2027
    Figure 2. Chlamydia Features
    Figure 3. Syphilis Features
    Figure 4. Gonorrhea Features
    Figure 5. Herpes Simplex Virus Features
    Figure 6. Human Papilloma Virus Features
    Figure 7. Human Immunodeficiency Virus Features
    Figure 8. Others Features
    Figure 9. Global Sexually Transmitted Diseases (STD) Testing Market Share by Application: 2020 VS 2027
    Figure 10. Laboratory Testing Case Studies
    Figure 11. Point of Care (POC) Testing Case Studies
    Figure 12. Sexually Transmitted Diseases (STD) Testing Report Years Considered
    Figure 13. Global Sexually Transmitted Diseases (STD) Testing Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Sexually Transmitted Diseases (STD) Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Sexually Transmitted Diseases (STD) Testing Market Share by Regions: 2020 VS 2027
    Figure 16. Global Sexually Transmitted Diseases (STD) Testing Market Share by Regions (2022-2027)
    Figure 17. Global Sexually Transmitted Diseases (STD) Testing Market Share by Players in 2020
    Figure 18. Global Top Sexually Transmitted Diseases (STD) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sexually Transmitted Diseases (STD) Testing as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases (STD) Testing Revenue in 2020
    Figure 20. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2016-2021)
    Figure 21. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2022-2027)
    Figure 22. North America Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Sexually Transmitted Diseases (STD) Testing Market Share by Type (2016-2027)
    Figure 24. North America Sexually Transmitted Diseases (STD) Testing Market Share by Application (2016-2027)
    Figure 25. North America Sexually Transmitted Diseases (STD) Testing Market Share by Country (2016-2027)
    Figure 26. United States Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Sexually Transmitted Diseases (STD) Testing Market Share by Type (2016-2027)
    Figure 30. Europe Sexually Transmitted Diseases (STD) Testing Market Share by Application (2016-2027)
    Figure 31. Europe Sexually Transmitted Diseases (STD) Testing Market Share by Country (2016-2027)
    Figure 32. Germany Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Share by Region (2016-2027)
    Figure 42. China Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Type (2016-2027)
    Figure 50. Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Application (2016-2027)
    Figure 51. Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Country (2016-2027)
    Figure 52. Mexico Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Share by Country (2016-2027)
    Figure 58. Turkey Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. ROCHE HOLDINGS Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
    Figure 62. BIOMERIEUX Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
    Figure 63. HOLOGIC Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
    Figure 64. BECTON DICKINSON Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
    Figure 65. ORASURE Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
    Figure 66. DANAHER Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
    Figure 67. AFFYMETRIX Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
    Figure 68. ABBOTT LABORATORIES Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
    Figure 69. BIO-RAD LABORATORIES Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
    Figure 70. DIASORIN Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ROCHE HOLDINGS
BIOMERIEUX
HOLOGIC
BECTON DICKINSON
ORASURE
DANAHER
AFFYMETRIX
ABBOTT LABORATORIES
BIO-RAD LABORATORIES
DIASORIN
Frequently Asked Questions
Sexually Transmitted Diseases (STD) Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Sexually Transmitted Diseases (STD) Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Sexually Transmitted Diseases (STD) Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Super Hi-Vision

The super hi-vision is a digital video format referred to as ultra-high definition (UHD) picture  ... Read More